BioTech ICCM IceCure Medical Wins Regulatory Approval To Market ProSense In China September 10, 2026 — 11:13 am EDT Written by RTTNews.com for RTTNews linkedin facebook x email reddit (RTTNews) - IceCure Medical Ltd. (ICCM), a developer of minimally invasive cryoablation therapies, announced that China's National Medical Products Administration (NMPA) has granted regulatory approval for its ProSense system. The device is designed to destroy benign and malignant tumors by freezing them, offering a non-surgical alternative for patients. ProSense uses liquid nitrogen-based cryoablation to freeze and ablate tumors in breast, kidney, bone, and lung. The system is already cleared in the U.S., Europe and several other markets, and the new approval in China significantly expands its global reach. Cryoablation is performed under imaging guidance, allowing physicians to target tumors precisely while sparing surrounding healthy tissue. The approval was supported by clinical data demonstrating ProSense's safety and efficacy, particularly in breast tumors. IceCure highlighted that cryoablation can be performed in outpatient settings, reducing recovery time and healthcare costs compared to traditional surgery. CEO Eyal Shamir said the NMPA decision "marks a major milestone in our mission to make ProSense available to patients worldwide," noting that China represents one of the largest healthcare markets globally. With this authorization, IceCure plans to accelerate commercialization efforts in China through local partnerships, aiming to provide physicians and patients with access to advanced cryoablation technology. The company recently implemented a 1-for-30 reverse stock split on June 4, 2026. ICCM is currently trading at $2.14, up 1.42%. RTTNews Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges. More articles by this source facebook x website Tags BioTech Stocks Mentioned ICCM Latest Articles Data is currently not available